Which mutual funds hold Natco Pharma Limited?

17 mutual funds hold Natco Pharma Limited as of Aug 2026. The highest weight is 1.41% held by Sundaram Long Term Micro Cap Tax Advantage Fund Series VI Direct Plan - Growth. Data from official AMFI monthly portfolio disclosures.

What sector is Natco Pharma Limited in?

Natco Pharma Limited is in the Pharmaceuticals & Biotechnology sector and is categorised as by SEBI.

What is the SEBI market cap category of Natco Pharma Limited?

As per SEBI and AMFI classification (Jan-Jun 2026), Natco Pharma Limited is a Small Cap stock ranked #380 with an average market cap of ₹17.39 K Cr.

Pharmaceuticals & Biotechnology

Natco Pharma Limited

ISIN: INE987B01026 · Data as of Aug 2026

Share: WhatsApp ✕ X

Search another stock:

Active Funds Holding

vs Last Month

+2 funds

Total Value

₹205.79 Cr

Avg Weight

0.93%

New Entries

Exits

Top Holder

Sundaram Long Term Micro Cap Tax Advantage Fund Series VI Direct Plan - Growth 1.41%

ℹ️ Index funds and ETFs are excluded. Only actively managed funds reflect genuine fund manager decisions.

Small Cap Rank #380

₹10.54 K Cr

Avg Mkt Cap · Jan-Jun 2023 (3yr ago)

→

₹17.39 K Cr

Avg Mkt Cap · Jan-Jun 2026 (latest)

+65%

3yr change

SEBI · AMFI Market Cap List

📋 What Changed This Month Natco Pharma Limited is currently held by 17 active mutual funds with total exposure of ₹205.79 Cr. This month 4 funds entered and 2 funds exited. Sundaram Long Term Micro Cap Tax Advantage Fund Series VI Direct Plan - Growth has the highest allocation at 1.41%. ↓ Scroll down for full fund list and monthly changes.

Trend

How Has Fund Coverage Changed — Last 5 Months?

Month	Funds	AUM (Cr)	AMCs	Status
Aug 2026 REFERENCE	17	₹206	49 / 49	✅ Complete
Jul 2026	15	₹229	49 / 49	✅ Complete
Jun 2026	18	₹231	49 / 49	✅ Complete
May 2026	20	₹260	49 / 49	✅ Complete
Apr 2026	16	₹252	49 / 49	✅ Complete

📌 Portfolio changes below are based on Aug 2026 data — the most complete month with 49 AMCs we cover uploaded.

This Month

What Changed in the Portfolio — Aug 2026?

Note: Index funds and ETFs are excluded from this analysis. Their holdings change due to index rebalancing, not active fund manager decisions, and do not reflect genuine conviction buys or exits.

▲ New Entries (4)

NJ Value Fund 1.23%

ADITYA BIRLA SUN LIFE PHARMA & HEALTHCARE FUND 0.92%

ICICI Prudential ESG Exclusionary Strategy Fund - Direct Plan - Growth 0.5%

JioBlackRock Sector Rotation Fund - Direct Plan - Growth Option 0.06%

▼ Exits (2)

SAMCO FLEXICAP FUND 2.67%

Franklin India Multi-Factor Fund- Direct- Growth 0.37%

↑ Increased (2)

THE WEALTH COMPANY FLEXI CAP FUND +0.04%

JM Value Fund (Direct) - Growth Option +0.01%

↓ Decreased (10)

Sundaram Long Term Micro Cap Tax Advantage Fund Series VI Direct Plan - Growth -0.13%

Sundaram Long Term Micro Cap Tax Advantage Fund Series III Direct Plan - Growth -0.13%

Sundaram Long Term Tax Advantage Fund Series IV Direct Plan - Growth -0.09%

Sundaram Long Term Micro Cap Tax Advantage Fund Series IV Direct Plan - Growth -0.13%

Sundaram Long Term Tax Advantage Fund Series III Direct Plan - Growth -0.11%

Sundaram Long Term Micro Cap Tax Advantage Fund Series V Direct Plan - Growth -0.14%

Sundaram Small Cap Fund Direct Plan - Growth -0.32%

Tata Value Fund -Direct Plan Growth Option -0.21%

By Category

Which Fund Categories Hold This Stock?

Category	Funds	Avg Weight
Equity	9	1.09%
Value/Contra	3	0.79%
Flexi Cap	2	0.72%
Small Cap	2	0.74%
Multi Cap	1	0.75%

All Holdings

Which 17 Active Funds Hold Natco Pharma Limited?

Filter:

Fund ↕	Category ↕	Weight ↕	Value ↕	Change ↕
Sundaram Long Term Micro Cap Tax Advantage Fund Series VI Direct Plan - Growth Sundaram Mutual Fund	Equity	1.41%	₹52.02 L	-0.13%
Sundaram Long Term Micro Cap Tax Advantage Fund Series III Direct Plan - Growth Sundaram Mutual Fund	Equity	1.4%	₹1.09 Cr	-0.13%
THE WEALTH COMPANY FLEXI CAP FUND The Wealth Company Mutual Fund	Flexi Cap	1.4%	₹3.52 Cr	+0.04%
Sundaram Long Term Tax Advantage Fund Series IV Direct Plan - Growth Sundaram Mutual Fund	Equity	1.39%	₹31.53 L	-0.09%
Sundaram Long Term Micro Cap Tax Advantage Fund Series IV Direct Plan - Growth Sundaram Mutual Fund	Equity	1.38%	₹51.41 L	-0.13%
Sundaram Long Term Tax Advantage Fund Series III Direct Plan - Growth Sundaram Mutual Fund	Equity	1.37%	₹47.76 L	-0.11%
Sundaram Long Term Micro Cap Tax Advantage Fund Series V Direct Plan - Growth Sundaram Mutual Fund	Equity	1.35%	₹43.24 L	-0.14%
NJ Value Fund NJ Mutual Fund	Value/Contra	1.23%	₹2.47 Cr	NEW
Sundaram Small Cap Fund Direct Plan - Growth Sundaram Mutual Fund	Small Cap	1.12%	₹46.43 Cr	-0.32%
ADITYA BIRLA SUN LIFE PHARMA & HEALTHCARE FUND Aditya Birla Sun Life Mutual Fund	Equity	0.92%	₹10.10 Cr	NEW
BANDHAN MULTI CAP FUND - GROWTH - DIRECT PLAN Bandhan Mutual Fund	Multi Cap	0.75%	₹23.14 Cr	—
Tata Value Fund -Direct Plan Growth Option Tata Mutual Fund	Value/Contra	0.68%	₹58.91 Cr	-0.21%
ICICI Prudential ESG Exclusionary Strategy Fund - Direct Plan - Growth ICICI Prudential Mutual Fund	Equity	0.5%	₹6.73 Cr	NEW
JM Value Fund (Direct) - Growth Option JM Financial Mutual Fund	Value/Contra	0.46%	₹3.79 Cr	+0.01%
Tata Small Cap Fund-Direct Plan-Growth Tata Mutual Fund	Small Cap	0.35%	₹46.20 Cr	-0.05%
JioBlackRock Sector Rotation Fund - Direct Plan - Growth Option JioBlackRock Mutual Fund	Equity	0.06%	₹10.27 L	NEW
JioBlackRock Flexi Cap Fund - Direct Plan - Growth Option JioBlackRock Mutual Fund	Flexi Cap	0.03%	₹1.05 Cr	-0.09%

Explore More

← Stock Search Top Stocks by MF Conviction Fund Directory AMC AAUM Rankings Market Cap Categories

Data source: Official AMFI monthly portfolio disclosures. Updated every month. Index funds and ETFs excluded. Disclaimer: This is not investment advice. Consult a SEBI-registered advisor before investing.